OncoDiag is a French biotechnology company based in Normandy at one hour from Paris and Rouen cities.
OncoDiag is a French biotechnology company based in Normandy at one hour from Paris and Rouen cities. The company is focused on developing of non-invasive diagnostic tests for early detection of cancers. Its lead product the Urotest (CE-IVD) is a urine test for diagnosis and surveillance of bladder cancer. The company's pipeline also includes the Colodiag in development for early detection of colorectal cancer.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Mar 15, 2021 | Series A | €2.50M | 3 | — | — | Detail |
Dec 20, 2018 | Angel | €600K | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
SFINE | — | Series A |
Normandie Business Angels | — | Series A |
Business Angels des Grandes Ecoles | — | Series A |